Journal ArticleDOI
Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
TLDR
This chapter about the recognition, treatment, and prevention of heparin-induced thrombocytopenia (HIT) is part of the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence Based Guidelines.About:
This article is published in Chest.The article was published on 2004-09-01. It has received 825 citations till now. The article focuses on the topics: Heparin-induced thrombocytopenia & Argatroban.read more
Citations
More filters
Journal ArticleDOI
Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association
Walter N. Kernan,Bruce Ovbiagele,Henry R. Black,Dawn M. Bravata,Marc I. Chimowitz,Michael D. Ezekowitz,Margaret C. Fang,Marc Fisher,Karen L. Furie,Donald V. Heck,S. Claiborne Johnston,Scott E. Kasner,Steven J. Kittner,Pamela H. Mitchell,Michael W. Rich,DeJuran Richardson,Lee H. Schwamm,John A. Wilson +17 more
TL;DR: In this paper, the authors provided evidence-based recommendations for the prevention of future stroke among survivors of ischemic stroke or transient ischemi-chemic attack, including the control of risk factors, intervention for vascular obstruction, antithrombotic therapy for cardioembolism, and antiplatelet therapy for noncardioembolic stroke.
Journal ArticleDOI
Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic Attack : A statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke : Co-sponsored by the Council on Cardiovascular Radiology and Intervention : The American Academy of Neurology affirms the value of this guideline
Ralph L. Sacco,Robert J. Adams,Greg Albers,Mark J. Alberts,Oscar R. Benavente,Karen L. Furie,Larry B. Goldstein,Philip B. Gorelick,Jonathan L. Halperin,Robert E. Harbaugh,S. Claiborne Johnston,Irene L. Katzan,Margaret Kelly-Hayes,Edgar J. Kenton,Michael P. Marks,Lee H. Schwamm,Thomas A. Tomsick +16 more
TL;DR: In this paper, the authors provide comprehensive and timely evidence-based recommendations on the prevention of ischemic stroke among survivors of stroke or transient ischemi stroke, including the control of risk factors, interventional approaches for atherosclerotic disease, antithrombotic treatments for cardioembolism, and the use of antiplatelet agents for noncardioembolic stroke.
Journal ArticleDOI
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
Karen L. Furie,Scott E. Kasner,Robert J. Adams,Gregory W. Albers,Ruth L. Bush,Susan C. Fagan,Jonathan L. Halperin,S. Claiborne Johnston,Irene L. Katzan,Walter N. Kernan,Pamela H. Mitchell,Bruce Ovbiagele,Yuko Y. Palesch,Ralph L. Sacco,Lee H. Schwamm,Sylvia Wassertheil-Smoller,Tanya N. Turan,Deidre Wentworth +17 more
TL;DR: Evidence-based recommendations are included for the control of risk factors, interventional approaches for atherosclerotic disease, antithrombotic treatments for cardioembolism, and the use of antiplatelet agents for noncardioembolic stroke.
Journal ArticleDOI
Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines: Report From an American College of Chest Physicians Task Force
Gordon H. Guyatt,David D. Gutterman,Michael H. Baumann,Doreen Addrizzo-Harris,Elaine M. Hylek,Barbara Phillips,Gary E. Raskob,Sandra Zelman Lewis,Holger J. Schünemann +8 more
TL;DR: An American College of Chest Physicians task force formulated the criteria for a grading system to be utilized in all ACCP guidelines that included simplicity and transparency, explicitness of methodology, and consistency with current methodological approaches to the grading process.
Journal ArticleDOI
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Shannon M. Bates,Ian A. Greer,Saskia Middeldorp,David L. Veenstra,Anne-Marie Prabulos,Per Olav Vandvik +5 more
TL;DR: In this article, the authors focused on the management of VTE and thrombophilia as well as the use of antithrombotic agents during pregnancy. But they did not consider the risk of pregnancy complications.
References
More filters
Journal ArticleDOI
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
Theodore E. Warkentin,Mark Levine,Jack Hirsh,Peter Horsewood,Robin S. Roberts,Michael Gent,John G. Kelton +6 more
TL;DR: Daily platelet counts in 665 patients in a randomized, double-blind clinical trial comparing unfractionated heparin with low-molecular-weight hepar in as prophylaxis after hip surgery revealed heparIn-induced thrombocytopenia, associated thromBotic events, and heParin-dependent IgG antibodies are more common in patients treated with unfractionate heparine than in those treated with low,molecules-weight He
Journal ArticleDOI
Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention: REPLACE-2 Randomized Trial
A. Michael Lincoff,John A. Bittl,Robert A. Harrington,Frederick Feit,Neal S. Kleiman,J. Daniel Jackman,Ian J. Sarembock,David J. Cohen,Douglas Spriggs,Ramin Ebrahimi,Gadi Keren,Jeffrey Carr,Eric A. Cohen,Amadeo Betriu,Walter Desmet,Dean J. Kereiakes,Wolfgang Rutsch,Robert G. Wilcox,Pim J. de Feyter,Alec Vahanian,Eric J. Topol +20 more
TL;DR: Bivalirudin with provisional Gp IIb/IIIa blockade is statistically not inferior to heparin plus planned Gp IIIa blockade during contemporary PCI with regard to suppression of acute ischemic end points and is associated with less bleeding.
Journal ArticleDOI
A 14-year study of heparin-induced thrombocytopenia
TL;DR: VenousThrombosis complicates heparin-induced thrombocytopenia more frequently than does arterial thromBosis, and the high risk of thROMbosis in patients initially recognized with isolated throma suggests that conventional management approaches require reappraisal.
Journal ArticleDOI
Temporal aspects of heparin-induced thrombocytopenia.
TL;DR: A fall in the platelet count beginning four or more days after the start of heparin therapy occurred in 170 of the 243 patients (70 percent); in these patients, a history of previousHeparin treatment did not influence the timing of the onset of thrombocytope...
Journal ArticleDOI
Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.
TL;DR: In patients undergoing orthopedic surgery, 2.5 mg of fondaparinux sodium once daily, starting 6 hours postoperatively, showed a major benefit over enoxaparin, achieving an overall risk reduction of VTE greater than 50% without increasing the risk of clinically relevant bleeding.